|Year : 2016 | Volume
| Issue : 5 | Page : 458-463
Antimicrobial effects of chlorhexidine, matrica drop mouthwash (chamomile extract), and normal saline on hospitalized patients with endotracheal tubes
Maryam Azimi1, Leila Jouybari2, Shahram Moghadam3, Ezatolah Ghaemi4, Naser Behnampoor5, Akram Sanagoo2, Moslem Hesam1
1 Department of Nursing, School of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran
2 Nursing Research Centre, Golestan University of Medical Sciences, Gorgan, Iran
3 Department of Anesthesiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
4 Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran
5 Department of Biostatistics, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran
|Date of Submission||18-Jan-2014|
|Date of Acceptance||21-May-2016|
|Date of Web Publication||4-Nov-2016|
Nursing Research Centre, Golestan University of Medical Sciences, Gorgan
Source of Support: None, Conflict of Interest: None
Clinical trial registration IRCT201204287821N1
Background: The functions and use of mouthwashes are variable depending on their type. Oral care in patients with endotracheal tubes is important to prevent side effects such as pneumonia. The aim of this study was to determine the antimicrobial effects of chlorhexidine, drop of Matrica mouthwash (chamomile extract), and normal saline on hospitalized patients with endotracheal tube in an intensive care unit (ICU).
Materials and Methods: In this clinical trial, 39 patients admitted to the ICU were selected by convenience sampling, were matched based on age and sex, and randomly assigned to three groups (chlorhexidine, Matrica, saline). Mouth washing was performed every 8 to 48 hours. The samples were taken at time zero (before the intervention) and 48 hours after the intervention for bacterial culture. Antibacterial activity of each mouthwash on microorganisms was measured based on the growth of Staphylococcus aureus, Pneumococcal, Enterococcus, Pseudomonas, and Escherichia coli. The obtained data were then analyzed using Chi-square and Fisher's exact tests with the Statistical Package for the Social Sciences Package version 18.
Results: Chlorhexidine mouthwash was more effective in preventing colonization of bacteria in the mouth (point probability = 0.06) in comparison with chamomile and saline mouthwashes. Nevertheless, none of the tested mouthwashes were able to remove pathogens, including Staphylococcus aureus, Pseudomonas, Klebsiella, and Acinetobacter.
Conclusions: 0.2% chlorhexidine mouthwash has a significant effect on the bacterial colonization rate in comparison with Matrica and normal saline mouthwashes in ICU hospitalized patients with endotracheal tube.
Keywords: Chlorhexidine mouthwash, ICU, Matrica, normal saline, pathogenic microorganisms
|How to cite this article:|
Azimi M, Jouybari L, Moghadam S, Ghaemi E, Behnampoor N, Sanagoo A, Hesam M. Antimicrobial effects of chlorhexidine, matrica drop mouthwash (chamomile extract), and normal saline on hospitalized patients with endotracheal tubes. Iranian J Nursing Midwifery Res 2016;21:458-63
|How to cite this URL:|
Azimi M, Jouybari L, Moghadam S, Ghaemi E, Behnampoor N, Sanagoo A, Hesam M. Antimicrobial effects of chlorhexidine, matrica drop mouthwash (chamomile extract), and normal saline on hospitalized patients with endotracheal tubes. Iranian J Nursing Midwifery Res [serial online] 2016 [cited 2021 May 10];21:458-63. Available from: https://www.ijnmrjournal.net/text.asp?2016/21/5/458/193390
| Introduction|| |
Provision of oral health care is one of the main tasks of health care providers and a fundamental aspect of nursing care in intensive care units (ICU).  This creates a sense of comfort and health and prevents dangerous complications such as ventilator-associated pneumonia (VAP).  Mouth is among the most critical organs in maintaining patients' health in ICUs because the artificial airway and nasogastric tube pass through this organ. However, these interventions result in opened mouth and impaired airway defense.  The earlier mentioned treatments make patients susceptible to developing plaque, oral health problems, and VAP due to decreased fluid intake, decreased salivation, lack of spontaneous motion in the tongue and jaw, difficulty in swallowing, and drug side effects.  According to the Center for Disease Control and Prevention (CDC), procedures that lead to hospital-acquired pneumonia include aspiration of pre-existing organisms in the oropharynx, inhalation of bacteria containing particles, infection spread through blood to other places, and transfer of bacteria from the gastrointestinal tract. Organisms' aspiration from the oropharynx is considered as the most pivotal procedure; reduction of hospital-acquired pneumonia is also caused by decrease of bacteria in the oropharynx.  Decontamination of mouth and throat using antifungal and antibacterial drugs is a common method to prevent aspiration of pre-existing bacteria in the mouth and throat. Commercial mouthwashes consist of a chemical formula including bis-biguanide (chlorhexidine and alexidine), antibiotics, enzymes, salts of heavy metals, halogens, sarcosines, and plant alkaloids that are consumed in the form of mouthwashes, gels, ointments, and toothpaste. In summary, using the abovementioned products increases the local concentration of drugs up to 100-fold greater than the systemic medication. Mouthwashes are oral irrigator solutions that are used for particular oral health conditions.  Chlorhexidine is a chemical agent that is widely used to reduce dental plaque. It is an antiseptic and disinfectant bis-biguanide that is effective against a wide range of bacteria as well as some fungi and viruses. Because of its lack of microbial resistance and carcinogenic effect, it can be utilized as a proper mouthwash solution.  Chlorhexidine prevents sticking of bacteria to the teeth and oral mucosa and causes damage to bacteria by increasing the permeability of bacterial cell walls and changing osmotic balance.  It has an inhibiting effect on both Gram-negative and positive bacteria and yeasts.  In addition, it has anti-microbial effects due to its gradual release in 12 h.  Although chlorhexidine is recommended as the most effective anti-plaque,  it is not yet recommended by the CDC due to lack of evidence in terms of its effectiveness and side effects (tooth discoloration, irritation of the mucous, and mucosal lesions).  A study by DeRiso et al.  regarding the effect of chlorhexidine mouthwash on ventilator-associated pneumonia in post-cardiac surgery patients, revealed that this procedure reduced hospital infections, especially respiratory infections, and decreased the use of antibiotics. Genuit et al.  also showed that use of chlorhexidine mouthwash leads to decreased removal time of endotracheal tube and reduces ventilator-associated pneumonia. Reduced incidence rate of pneumonia due to the use of chlorhexidine mouthwash was also observed in a study by Houston et al.  However, because of the side effects of using the said mouthwash, medical science has been recently more inclined to plant extracts because of their appropriate therapeutic effects and low side effects.
Chamomile is suggested as a standard medicinal plant because of its numerous treatment benefits. It has anti-bacterial, anti-viral and anti-fungal effects, as well as contains compounds that are effective against Staphylococcus aureus and Candida. In a study by Pourabbas et al.,  the authors aimed at determining the effect of Matrica mouthwash on plaque of 25 patients with gingivitis, the average reduction of plaque and gums due to mouthwash provided by chamomile was significantly more than that of the mouthwash used in the control group.
According to a research regarding the use of this mouthwash, Kamillosan maintains the natural condition of the mouth and reduces the severity of mucositis and accelerates re-epithelialization of tissue in the mouth. No patients were allergic or complained about its taste after chamomile consumption.  Therefore, this study aimed to investigate the anti-bacterial effects of the three abovementioned mouthwashes on mouth bacterial colonies.
| Materials and Methods|| |
A double-blind, randomized clinical trial with a control group was implemented. The study participants were newly admitted patients to the ICU of the fifth Azar Hospital in Gorgan (Northern Iran) who had an endotracheal tube during the study and were also expected to remain connected to the ventilator for more than 48 h. Inclusion criteria included hospitalization in the ICU, age of 15 years or more, having an endotracheal or nasogastric tube, mechanical ventilation for 48 h, lack of aspiration, lack of antibiotic treatment before hospitalization, lack of sensitivity to the mouthwashes, asthma, allergic inflammation of the nose and skin, lack of radiation exposure, and immunosuppressive drugs such as corticosteroids, and no consumption of any antimicrobial mouthwash in 2 months prior to hospitalization. In total, 39 eligible participants were included in the study. Re-intubation, lung infection, reaction to any mouthwashes, death, or transfer of the patient to another unit were the excluding criteria. The Iranian Registry of Clinical Trial code for the study is IRCT201204287821N1.
According to the methods reported by Taraghi et al.  13 samples were assigned to each group. First, samples were selected by convenient sampling from hospitalized patients in the ICU, and then they were randomly distributed between the two groups. Written consent form was obtained from the patients. Each hospitalized eligible participant randomly selected a sheet from a box containing 13 sheets mentioning chlorhexidine mouthwash, 13 sheets mentioning Matrica mouthwash, and 13 sheets mentioning saline. The patients were then divided into three groups after matching age and gender. Data were collected using a bipartite checklist including demographic characteristics (age and gender) and clinical history (disease diagnosis, consumed drugs, and comorbid diseases). Laboratory tools were sterile swabs, Falcon tubes, blood agar culture medium, MSA (Mannitol Salt Agar), EMB (Eosin Methylene Blue Agar), MHA (Mueller Hinton Agar), Bile esculin, in vitro diagnostics, TSI (Triple Sugar Iron Agar), OF (Oxidation Fermentation), MRVP (Methyl Red Voges Proskauer) SIM (Sulfide Indole Motility), CS (Citrate Simmons), urea, diagnostic discs, sheep blood, and disposable plates.
The researcher was attending the ICU daily and the selected eligible hospitalized. Then, demographic and consent forms were filled by the participants. Before intervention, researcher washed hands for 30 s with soap and water.
In the first experimental group, 0.2% chlorhexidine mouthwash and in the second group Matrica mouthwash were used, whereas the control group received normal saline. At the time of admission, four swabs were taken from the upper posterior oropharynx and at the bedside; one swab was cultured on the blood agar medium and the remaining three swabs were transferred to a tube containing 0.5-1 ml transport medium, and finally, mouthwash was consumed. In all the study groups, the entire mouth surface, teeth, tongue, palate, and inside the cheeks were washed three times per day for 6 min with 10 ml of mouthwash, following which oropharynx sterile suctioning was carried out. Mouthwash was given every 8 h for 48 h, and then the patients were checked again. Other three swabs were transferred to the Laboratory of Microbiology located in the Faculty of Medicine for a maximum time of 1 h. In the laboratory, samples were cultured in EMB, MSA, Bile Esculin (BB), and BA and were put on a candlestick whereas others were put in an incubator at 37°C for 24 h. According to the microbial growth of Pneumococcus, S. aureus, Enterococcus, Pseudomonas, Escherichia coli, after 24 h, plates were evaluated for the identification of bacteria and its type by colony morphology and initial screening. To prevent bias, all testing processes were carried out by a lab specialist who was unaware of the intervention. Finally, all the findings were coded (double-blinded study was implemented). It implies that the laboratory and statistical analysis experts were unaware of the sample assignment in the groups. For data analysis, Chi-square and Fisher tests were carried out using the Statistical Package for the Social Sciences (SPSS Inc. version 18) and P value and test power of 0.05 and 90%, respectively, were considered as statistically significant.
The ethical and scientific contents of this study have been approved by research ethics committee of Golestan University of Medical Sciences. This study registered at Iranian Registry of Clinical Trials with Registry code: IRCT201204287821N1.
| Results|| |
Among the 39 enrolled patients, 21 were males (53.84%) and 18 were females (46.15%). Subjects' age was in the range of 20 to 68 years with the mean and standard deviation of 43.64 ± 15.01. With regards to matching at the first stage, there was no significant difference between age (P = 0.595), gender (P = 0.758), diagnosis (P = 0.407), and level of consciousness (P = 0.066) with received antibiotics, antacids, and sedation in the three groups [Table 1].
|Table 1: Demographic information and clinical characteristics of the studied ICU patients in all three test groups (Chlorhexidine, Matrica, Normal Saline)|
Click here to view
Bacterial culture of the obtained samples before mouthwash consumption indicated that bacterial growth was only observed in 11 (28.2%) patients whereas 2 (5.1%), 4 (10.3%), 3 (7.7%), and 2 (5.1%) had S. aureus, Pseudomonas, Klebsiella, and Acinetobacter, respectively [Table 2]. Results of the bacterial cultures, 48 h after the usage of mouthwash, revealed that 18 patients (46.2%) in the second culture had no growth of any bacteria compared to the first 28 patients. The most grown pathogen was Klebsiella (20.5%) followed by Pseudomonas (17.9%). Findings also revealed that patients infected by S. aureus, Pseudomonas, Klebsiella, and Acinetobacter before mouthwash consumption, after 48 h had no change in their bacterial condition and mouthwash was not able to eliminate these pathogens. Mouth bacterial condition after mouthwash consumption indicated that 11 patients before the application of chlorhexidine mouthwash had no growth of some bacteria, and 48 h after usage, only one positive sample was found. For Matrica mouthwash, 8 patients before mouthwash usage and 5 patients 48 h after the consumption were positive. Finally, in normal saline, 9 patients before consumption and 6 patients after application were positively infected [Table 3].
|Table 2: The frequency distribution of ICU patients with intubation, based on mouth bacterial condition at the time of admission and 48 hours after intervention|
Click here to view
|Table 3: The frequency distribution of mechanically ventilated ICU patients, based on isolated type of microorganisms from secretions of samples before and 48 hours after intervention|
Click here to view
| Discussion|| |
The results of this study revealed that 0.2% chlorhexidine mouthwash is more effective in preventing bacterial colony growth compared to Matrica mouthwash and normal saline. The primary colonization rate in this study was 28.2%, in the chlorhexidine, Matrica, and normal saline group, it was 5.12, 12.82, and 10.25%, respectively. After 48 h, colonization rates were 53.7, 7.69% for the first group, 20.51% for the second group, and 25.64% for the third group. The findings of Ozcaka et al.  also represented the effectiveness of 0.2% chlorhexidine on on reducing the incidence of ventilator-associated pneumonia. Scannapieco et al.  also demonstrated that chlorhexidine reduces the number of S. aureus bacteria in ventilated patients, whereas it was unable to reduce other pathogens.
Gram-negative bacteria were the most common isolated microorganisms from the samples and the majority of grown pathogens were Klebsiella and P. aeruginosa. These results are relevant with that of Ghazvini et al. in which K. pneumonia was the most frequently isolated bacteria from the throat, followed by Acinetobacter baumannii, P. aeruginosa, and different strains of Enterobacteriaceae.  In Panchabhai  study, the most common isolated pathogens were P. aeruginosa, A. baumannii, K. pneumonia, and S. aureus.
In our study, on the first day, sampling was carried out at two different times and after 48 h, and then changes in bacterial colonization were assessed in the three test groups. The findings revealed that colonization rate increased on the second day, whereas results of Berry et al.  indicated that colonization increased and there was no difference between the three groups on the fourth day compared to the first day of colonization. In this study, 23.1% of the normal saline group and 76.9% in the chlorhexidine group had no bacterial growth and K. pneumonia was the most common pathogen. Seyedalshohadaee et al.  reported that 72.3% of patients in the saline group had no pathogen growth whereas in the chlorhexidine group, no microorganism growth was found in 81.5% of the patients. The most common pathogen in both groups was A. baumannii. The gradual release of chlorhexidine leads to relatively long-term effects of antimicrobial substances in the mouth. Chlorhexidine stays active for 6 h in the tissues. According to the Dental Association of America, the standard procedure of chlorhexidine usage is 10 ml of 0.12% chlorhexidine mouthwash for 1 min twice daily in healthy individuals. In several clinical trials, concentration of 0.12 and 0.2% for 1-4 times daily usage as a mouthwash or gel has been implemented because there is no agreement on its concentration and frequency of usage in the ICU. No significant difference was observed in the elimination of pathogens and the incidence of pneumonia related to ventilator in the said studies; in contrast, 2% chlorhexidine has a significant impact on reducing the incidence of ventilator-associated pneumonia. These findings suggest the usage of higher concentrations of chlorhexidine in ICUs.  In a study by Munro,  0.12% chlorhexidine swab was not effective on bacteria colonization, however, in a study by Forier,  0.2% chlorhexidine gel resulted in a decrease in positive cultures on days 5, 7, and 10, with no effect on colonization after 10 days. In this study, 0.2% chlorhexidine was used three times daily for every 8 h, which was more effective for bacteria colonization compared to the other two tested mouthwashes. However, in the study by Ranjbar et al.  and Faridian  where 0.2 and 0.12% chlorhexidine mouthwash were used, results revealed no statistically significant difference between chlorhexidine and saline group in terms of type and amount of isolated bacteria from patients with ventilator-associated pneumonia.
The oropharynx of patients in our study receiving mechanical ventilation was quickly colonized by Gram-negative microorganisms. Although it is believed that the maximum growth of microorganisms is within 96 h after intubation, 28.2% of our participants were colonized by these microorganisms during the first 12 h of admission. Because the admitted patients to the ICU usually have unstable conditions in the first 24 to 48 h, most nursing cares are focused on stabilizing the patient's hemodynamic status; thus, oral care is not a high priority.  The study by Grap et al.  indicated that 0.12% chlorhexidine in the forms of swab or spray may prevent the development of ventilator-associated pneumonia immediately after intubation and reduce microorganisms' growth in the oral cavity.
In our study, while there was no significant relationship between the diagnosis and microorganisms' colonization, 48 h after mouthwash usage, Cendrero  revealed that trauma increases the risk of S. aureus colonization. There is no consensus regarding the effects of age on ventilator-associated pneumonia, however, some studies have hypothesized that age over 70 years can be a risk factor for nosocomial pneumonia.  In this study, the age of over 65 years was introduced as a risk factor of ventilator-associated pneumonia; however, age is an independent risk factor of colonization with Gram-negative bacilli.  The mean age of patients in this study was 43.64 ± 15.01, and there was no significant relationship between age and colonization of bacteria. There is no agreement on the impact of gender on the incidence of ventilator-associated pneumonia.  Some studies mentioned the male and others female gender as a risk factor for VAP. The results of this study, showed no significant difference between the two sexes in terms of growth of microorganisms. It might be the result of inadequate samples in our research and it is also recommended to implement more studies with various designs. Effects of 0.2% chlorhexidine on mouth bacteria with Matrica mouthwash have been previously studied in healthy individuals, but no identical study has yet been conducted on ICU patients. Therefore, our results are only compared to a few in vitro studies that have been implemented on healthy individuals. The results of the study by Atai  revealed that herbal mouthwash has significantly less antibacterial effects than chlorhexidine mouthwash; meanwhile, the antibacterial effects of Matrica mouthwash was substantially more efficient compared to other mouthwashes. In our study, the antibacterial effect of 0.2% chlorhexidine mouthwash was higher than normal saline and Matrica mouthwash.
| Conclusion|| |
This study shows that use of 0.2% chlorhexidine three times daily has more ability to prevent the growth of bacterial colonies in mouth compared to saline and Matrica mouthwashes. However, further research with larger sample sizes are recommended in order to determine the effects of Matrica mouthwash.
The authors wish to thank the Nursing Research Center and Deputy of Research, Golestan University of Medical Science, as well as the officials and ICU staff of the 5 th Azar Teaching Hospital for their support. We would also like to thank all the patients and their families for participating in the study.
Financial support and sponsorship
This article was derived from a master thesis of Maryam Azimi at Golestan University of Medical Sciences, Gorgan, Iran.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Rello J, Koulenti D, Blot S, Sierra R, Diaz E, De Waele JJ, et al
. Oral care practices in intensive care units: A survey of 59 European ICUs. Intensive Care Med 2007;33:1066-70.
Blot S, Vandijck D, Labeau S. Oral care of intubated patients. Clin Pulm Med 2008;15:153.
Dale C, Angus JE, Sinuff T, Mykhalovskiy E. Mouth care for orally intubated patients: A critical ethnographic review of the nursing literature. Intensive Crit Care Nurs 2013;29:266-74.
Fourrier F, Dubois D, Pronnier P, Herbecq P, Leroy O, Desmettre T, et al
. Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: A double-blind placebo-controlled multicenter study. Crit Care Med 2005;33:1728-35.
Houston S, Hougland P, Anderson J, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002;11:567-70.
Moozeh MM. Periodontology & Periodontics for Dentistry Health Assistant, 1 st
Ed; 1996. pp. 99-143 [Persian].
Postma D, Sankatsing S, Thijsen S, Endeman H. Effects of chlorhexidine oral decontamination on respiratory colonization during mechanical ventilation in intensive care unit patients. Infect Control Hosp Epidemiol 2012;33:527.
Pedreira ML, Kusahara DM, de Carvalho WB, Núñez SC, Peterlini MA. Oral care interventions and oropharyngeal colonization in children receiving mechanical ventilation. Am J Crit Care 2009;18:319-28.
Bouza E, Burillo A. Advances in the prevention and management of ventilator-associated pneumonia. Curr Opin Infect Dis 2009;22:345:22.
Berry AM, Davidson PM, Masters J, Rolls K. Systematic literature review of oral hygiene practices for intensive care patients receiving mechanical ventilation. Am J Crit Care 2007;16:552-62.
DeRiso AJ, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996;109:1556-61.
Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman MC. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect 2001;2:5-18.
Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002;11:567-70.
Pourabbas R, Delazar A, Chitsaz MT. The effect of German chamomile mouthwash on dental plaque and gingival inflammation. Iran J Pharm Res 2005;2:105-9.
Sadeghi M, Bahramabadi R, Assar S. Antibacterial effects of Persica and Matrica herbal mouthwashes on common oral microorganisms: An in vitro
study. J Mash Dent Sch 2011;35:107-14.
Taraghi Z, Khezri HD, Baradari AG, Gorji MA, Sharifpour A, Ahanjan M. Evaluation of the antibacterial effect of Persica® mouthwash in mechanically ventilated ICU patients: A double blind randomized clinical trial. Middle-East J Sci Res 2011;10:631-7.
Özçaka Ö, Baºoðlu ÖK, Buduneli N, Taºbakan M, Bacakoðlu F, Kinane D. Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: A randomized clinical trial. J Periodontal Res 2012;47:584-92.
Scannapieco FA, Yu J, Raghavendran K, Vacanti A, Owens SI, Wood K, et al
. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 2009;13:1-12.
Ghazvini K GJ, Malek Jafarian M, Yazdan Panah M, Irani N. Incidence of nosocomial pneumonia and bacterial agents causing this infection in Intensive Care Unit in Qaem university hospital in Mashhad. J of Ilam Uni of Med Sci 2005;13:55-61.
Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients an open-label randomized trial with 0.01% potassium permanganate as control. Chest J 2009;135:1150-6.
Berry AM, Davidson PM, Masters J, Rolls K, Ollerton R. Effects of three approaches to standardized oral hygiene to reduce bacterial colonization and ventilator associated pneumonia in mechanically ventilated patients: A randomized control trial. Int J Nurs Stud 2011;48:681-8.
Seyedalshohadaee M, Rafii F, Haghani H. Evaluating the effect of mouth washing with chlorhexidine on the ventilator associated pneumonia. Iran J of Nurs 2012;25:34-44.
Snyders O, Khondowe O, Bell J. Oral chlorhexidine in the prevention of ventilator-associated pneumonia in critically ill adults in the ICU: A systematic review. Southern African J Crit Care 2011;27:48-56.
Munro C, Grap M, Sessler C, McClish D. Effect of oral care interventions on dental plaque in mechanically ventilated ICU adults. Am J Crit Care 2007;16:309.
Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000;26:1239-47.
Ranjbar H, Jafari S, Kamrani F, Alavi Majd H, Yaghmayee F, Asgari A. Effect of Chlorhexidine gluconate oral rinse on preventing of late onset ventilator associated pneumonia and its interaction with severity of illness. Iran J Crit Care Nurs 2010;3:4-13.
Feider LL, Mitchell P, Bridges E. Oral care practices for orally intubated critically ill adults. Am J Crit Care 2010;19:175-83.
Grap MJ, Munro CL, Hamilton VA, Elswick R, Sessler CN, Ward KR. Early, single chlorhexidine application reduces ventilator-associated pneumonia in trauma patients. Heart Lung 2011;40:e115-22.
Cardeñosa Cendrero JA, Solé-Violán J, Bordes Benítez A, Noguera Catalán J, Arroyo Fernández J, Saavedra Santana P, et al
. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest J 1999;116:462-70.
Atai Z, Abdollahi H, Naderipour S, Mohammadi S. Comparison of antifungal and antibacterial effects of Persica Matrica and Iralwex with Chlorhexidine mouthwashes (An in vitro
study). J Dent School Shahid Beheshti Univ Med Sci 2007;25:58-65.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Systematic review: Effectiveness of herbal oral care products on ventilator-associated pneumonia
| ||Mojtaba Mojtahedzadeh,Mahdi Mashhadi Akbar Boojar,Solomon Habtemariam,Seyed Mohammad Nabavi,Atabak Najafi,Amirhosein Ghahremanian,Mohammad Baktash,Safieh Aghaabdollahian,Antoni Sureda,Mahdi Bagheri |
| ||Phytotherapy Research. 2021; |
|[Pubmed] | [DOI]|
||Fear and Practice Modifications among Dentists to Combat Novel Coronavirus Disease (COVID-19) Outbreak
| ||Muhammad Adeel Ahmed,Rizwan Jouhar,Naseer Ahmed,Samira Adnan,Marziya Aftab,Muhammad Sohail Zafar,Zohaib Khurshid |
| ||International Journal of Environmental Research and Public Health. 2020; 17(8): 2821 |
|[Pubmed] | [DOI]|
||Oral Chlorhexidine Against Ventilator-Associated Pneumonia and Microbial Colonization in Intensive Care Patients
| ||Elem Kocaçal Güler,Gülengün Türk |
| ||Western Journal of Nursing Research. 2019; 41(6): 901 |
|[Pubmed] | [DOI]|
||Gingival Inflammatory Indices and Dental Stain Index after Using Aloe Vera-Green Tea Mouthwash, Matrica Mouthwash, or 0.2% Chlorhexidine Mouthwash Compared with Placebo in Patients with Gingival Inflammation
| ||Jaber Yaghini,Narges Naghsh,Sayed Mohsen Sadeghi,Samaneh Soltani |
| ||The Open Dentistry Journal. 2019; 13(1): 214 |
|[Pubmed] | [DOI]|
||Oropharyngeal Bacterial Colonization after Chlorhexidine Mouthwash in Mechanically Ventilated Critically Ill Patients
| ||Béatrice La Combe,Anne-Claire Mahérault,Jonathan Messika,Typhaine Billard-Pomares,Catherine Branger,Luce Landraud,Didier Dreyfuss,Fadia Dib,Laurent Massias,Jean-Damien Ricard |
| ||Anesthesiology. 2018; 129(6): 1140 |
|[Pubmed] | [DOI]|
||The Effect of Ozonated Water and Chlorhexidine Gluconate on Prevention of Ventilator-Associated Pneumonia: A Double-Blind, Randomized, Clinical Trial
| ||Nasrin Hanifi,Masomeh Masoumi,Mohammad Reza Jamshidi,Soghrat Faghihzadeh |
| ||Iranian Red Crescent Medical Journal. 2017; In Press(In Press) |
|[Pubmed] | [DOI]|